Back to top

Latest News

Washing hands - Coronavirus (COVID-19) and MS
4 March 2020

Coronavirus (COVID-19) and MS

We know many people living with MS in Australia (and worldwide) are anxious about coronavirus – a new respiratory illness – and what it means for them.

Deidre Mackechnie, CEO, MS Australia says,

“we are aware of the concerns of the MS community in Australia. MS...

13 February 2020

Parliamentary Friends of Multiple Sclerosis - Briefing on the latest MS research developments

On Wednesday 12 February, MS Australia was delighted to host a Parliamentary Friends of MS event in Parliament House, Canberra.  The event was arranged in response to a request from...
astrid and adam
7 February 2020

MS Australia welcomes Adam Bandt as the new Greens Leader

MS Australia welcomes the election of Adam Bandt as the new Leader of the Australian Greens in the Australian Parliament.

MS Australia has always enjoyed a progressive and productive relationship with the Australian Greens, including representation on our...

6 February 2020

MS treatments on PBAC’s March 2020 agenda

It’s unusual to have three medications for treating MS before a meeting of the Pharmaceutical Benefits Advisory Committee (PBAC), for consideration for listing on the Pharmaceutical Benefits...

21 January 2020

NDIS Tune Review sets the scene for (long overdue) change

MS Australia joins other disability peak organisations in welcoming the Tune Review...

13 January 2020

Paralympian cyclist Emily Petricola talks to MS Australia about life with MS and training for Tokyo 2020.

Smart, funny and incredibly fit, Emily Petricola calls herself the “Queen of Denial”. “I prefer not to think about the things that are affecting my body”, says Emily.

Nevertheless, she is keen to work with MS Australia to broaden awareness of MS around the nation.  Emily feels...

8 January 2020

Are you in a current bushfire area?

If you are experiencing wheezing, chest tightness and difficulty breathing you should call triple zero (000) or TTY Emergency Service: Dial 106.

Please ensure you stay informed: 

State specific information


20 December 2019

PBS listing for Siponimod (brand name Mayzent®) for SPMS not recommended by PBAC

The Pharmaceutical Benefits Advisory Committee (PBAC) announced today (20/12/19), that they have not recommended the listing of siponimod (Mayzent®) for secondary progressive MS (SPMS) on the Pharmaceutical Benefits Scheme (PBS), stating as follows:

“The PBAC did not recommend the listing...

medicinal cannabis
18 December 2019

Application to list Sativex on the PBS

MS Australia has been informed by Emerge Health that they have made an application to the March 2020 meeting of the Pharmaceutical Benefits Advisory Committee (PBAC) to have the medicinal cannabis product Sativex listed on the Pharmaceutical Benefits Scheme (PBS) for spasticity in MS.  If...

Dr Leslie Sedal
26 November 2019

MS Australia pays tribute to the life of Dr Leslie (Ladislav) Sedal, M.B, B.S., FRACP, M Ed. (04/09/1944 - 16/11/2019)

Dr Sedal was a consultant neurologist, specialising in multiple sclerosis, who devoted his professional life to the care of his patients.  Dr Sedal also made a significant contribution to the education of medical students, health professionals and colleagues about MS and undertook clinical MS...
18 November 2019

MS Australia’s top award presented to Professor Michael Pender

Michael Pender MS Australia is thrilled to announce that Professor Michael...

28 October 2019

Australian Government approves amended PBS listing of two MS medications for children with RRMS, from 1 November 2019.

Today (Monday 28 October 2019) the Federal Health Minister, the Hon Greg Hunt MP announced the (amended) listing of two MS medications for children with relapsing remitting MS (RRMS) on the Pharmaceutical Benefits Scheme (PBS), from 1 November 2019.

The Federal Health Minister’s media...